Inverse association between IgG-anti-kappa and antierythrocyte autoantibodies in patients with cold agglutination

Citation
P. Terness et al., Inverse association between IgG-anti-kappa and antierythrocyte autoantibodies in patients with cold agglutination, BLOOD, 94(12), 1999, pp. 4343-4346
Citations number
18
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
94
Issue
12
Year of publication
1999
Pages
4343 - 4346
Database
ISI
SICI code
0006-4971(199912)94:12<4343:IABIAA>2.0.ZU;2-6
Abstract
It has been known for a long time that IgG-anti-F(ab')(2) antibodies (Abs) are able to suppress the B-cell response. We showed that natural IgG-anti-F (ab')(2) autoantibodies appear in the serum of patients with cold agglutina tion. If the anti-F(ab')(2) Ab suppresses cold agglutinin (CA)-producing B cells, one would expect an inverse correlation between the titers of these two Abs. Our study confirmed this correlation. Subsequent experiments showe d that some anti-F(ab')(2) Abs bind to the hinge region of IgG, It was diff icult to explain how this Ab suppresses CA-producing B cells, which are of IgM isotype. Here we show that patients with cold agglutination have an igG -anti-kappa light chain autoantibody in their serum. This is another member of the anti-F(ab')(2) Ab group. Because the vast majority of CAs are IgM-k appa Abs, the anti-kappa Ab might suppress CA-producing B cells. If this is the case, there should be an inverse association between the titer of anti -kappa Ab and CA. In a group of 302 patients, we found that high titers of the anti-kappa Ab correlate with low titers of CA and vice versa (P = .009) . Interestingly, this association is found only in patients whose disease i s caused by noninfectious agents, including mainly B-cell proliferations (P = .0058), Our data show that the inverse correlation is not confined to a particular CA autoantibody specificity. The results are discussed in the li ght of recent findings showing that anti-IgM Abs may either inactivate or k ill tumoral B cells by apoptosis, (C) 1999 by The American Society of Hemat ology.